942309-32-2

Upstream product

• 122225-42-7 3,4-cis-dihydroxy-pyrrolidine-1-carboxylic acid benzyl ester 
• 77-76-9 2,2-dimethoxy-propane 
• 31970-04-4 1-carboxybenzyl-3-pyrrolidine 

Downstream Products

• 1290056-88-0 4-cyano-N-(4-(2-(2,2-dimethyldihydro-3aH-[1,3]dioxolo[4,5-c]pyrrol-5(4H)-yl)-2-oxoethoxy)benzyl)benzamide 
• 1290056-96-0 tert-butyl 3-(1-(3-(2-(2,2-dimethyldihydro-3aH-[1,3]dioxolo[4,5-c]pyrrol-5(4H)-yl)-2-oxoethoxy)benzoyl)piperidin-4-yl)benzylcarbamate 
• 1290056-89-1 4-(aminomethyl)-N-(4-(2-((3aR,6aS)-2,2-dimethyldihydro-3aH-[1,3]dioxolo[4,5-c]pyrrol-5(4H)-yl)-2-oxoethoxy)benzyl)benzamide 
• 152139-64-5 (meso)-3,4-isopropylidenedioxy-2,5-pyrrolidine hydrotosylate 

Relevant academic research and scientific papers

COFERONS AND METHODS OF MAKING AND USING THEM

The present invention is directed to a monomer useful in preparing therapeutic compounds. The monomer includes one or more pharmacophores which potentially binds to a target molecule with a dissociation constant of less than 300 μM and a linker element connected to the pharmacophore. The linker element has a molecular weight less than 500 daltons, is connected, directly or indirectly through a connector, to the pharmacophore.